Managing regulatory risk
As China’s regulatory action against big tech eases due to the rising economic headwinds, various regulatory developments, such as merger reforms, data and cyber-security regulations, sanctions, ESG, are increasingly keeping M&A professionals on high alert. On the listing side, the recent signing of a protocol agreement between the Public Company Accountability Board (PCAOB) and the China Securities Regulatory Commission might be the first step in preventing companies from being de-listed from US exchanges and could be a game changer for the regional IPO market. A panel of leading experts will examine key challenges ahead and effective strategies to mitigate regulatory risk.
- What are the current regulatory developments influencing deals and listings?
- Data privacy and cyber-security – are they more important than ever?
- Emerging trends-ESG, sanctions, killer acquisitions
- What is the impact of the China/US protocol agreement on the market?
An error occurred trying to play the stream. Please reload the page and try again.Close